Table 2.
Mouse lines | GH level | IGF-1 level | Body size / Weight | Body composition | Bone growth | Insulin sensitivity | Reproductive capacity | Cancer incidence | Other notes | References |
---|---|---|---|---|---|---|---|---|---|---|
JAK2 KO | Lethal | Erythropoiesis impaired | [75] | |||||||
STAT5b KO | ↑ (male only) | ↓ (both sexes) | ↓ (males only) | ↓ adipose tissue | ↓ (males only) | Poor lactation; deficient pregnancy | Varies by genetic background | Delay of hair growth; GH pulse-resistant | [69, 70, 76, 77] | |
SOCS2 TG | ↑ | ↓ adipose tissue | Fertile | [71] | ||||||
SOCS2 KO | ↑ local IGF-1; no difference in serum | ↑ | ↔ | ↑ | ↔ | Thickening of dermis; excessive collagen deposition | [78, 79] | |||
ALS KO | ↔ | ↓ serum IGF-1 and IGFBP3 | ↓ | ↓ bone mineral density | ↔ | ↔ | [80, 81] | |||
IGF-1 KO | Below detection limits | ↓ | ↓ | Infertile | High neonatal lethality (less than that of IGFR −/−), only 68% reach adulthood | [82, 83] | ||||
IGFBP3-KO | ↔ | ↔; ↓ | No change at birth; ↑ overall weight | ↑ muscle mass; ↓ WAT mass | ↑ fasting blood glucose, ↑ insulin, impaired GTT | ↔ | ↑lung cancer progression | ↓ plasma TG adiponectin levels;↓ metabolic rate | [84–86] |